We are developing an active implantable medical device, named CaverSTIM, to restore the erectile function of post-prostatectomy patients or others non-responsive to oral drugs (e.g. Viagra or Cialis). To achieve erection, these patients resort to intrapenial injections of vasodilators or penile implants, which are quite problematic and outdated, but the only option for a large population (approx. 1B existing market). CaverSTIM offers a far better therapeutic modality for an under-addressed market.
New studies validate Aesyra and Comphya devices (startupticker.ch)
Swiss medtechs report clinical progress in heart, brain, and rrological health (startupticker.ch)
Swiss medtechs report clinical progress in heart, brain, and urological health (startupticker.ch)
Comphya closes CHF 7.5M Series A to advance erectile dysfunction therapy (venturelab.swiss)
Additional funding brings Comphya’s series A to CHF 7.5 million (startupticker.ch)
Comphya secures CHF 4.35M in Series A first tranche to support CaverSTIM clinical trials (venturelab.swiss)
Comphya secures Series A First Tranche of CHF 4.35M (startupticker.ch)
Comphya receives FDA IDE approval to initiate clinical trials in the US (startupticker.ch)
Swiss medtech startups enter next development phase (startupticker.ch)
World first medical device implantation to restore erectile function (startupticker.ch)
Comphya launches clinical study with spinal chord injury patients (startupticker.ch)
Comphya receives approval for first long-term implantation clinical trial (startupticker.ch)
Comphya raises funds for clinical trials (startupticker.ch)
Startup internationalisation camp in the US in progress (startupticker.ch)
Tech tour presents 12 winners from Switzerland (startupticker.ch)
Alpine Techstars to attract investors (startupticker.ch)
Comphya raises additional USD 1.3 million (startupticker.ch)
Comphya raises CHF 1.3M for clinical trials execution (venturelab.swiss)
10 Swiss Medtech Startups to Watch in 2020 (venturelab.swiss)
IMD Startup competition reveals the winners of the 2019/2020 edition (startupticker.ch)
Start of 2 Pilot Clinical Trials